A detailed history of Lynch & Associates transactions in Stryker Corp stock. As of the latest transaction made, Lynch & Associates holds 18,381 shares of SYK stock, worth $6.7 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares
18,381
Previous 18,209 0.94%
Holding current value
$6.7 Million
Previous $6.2 Million 7.17%
% of portfolio
1.42%
Previous 1.41%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$315.94 - $371.96 $54,341 - $63,977
172 Added 0.94%
18,381 $6.64 Million
Q2 2024

Aug 06, 2024

BUY
$324.3 - $354.67 $278,249 - $304,306
858 Added 4.94%
18,209 $6.2 Million
Q1 2024

Apr 09, 2024

SELL
$293.94 - $358.71 $302,170 - $368,753
-1,028 Reduced 5.59%
17,351 $6.21 Million
Q4 2023

Jan 08, 2024

BUY
$253.85 - $299.46 $28,938 - $34,138
114 Added 0.62%
18,379 $5.5 Million
Q3 2023

Oct 24, 2023

SELL
$266.54 - $302.43 $3,998 - $4,536
-15 Reduced 0.08%
18,265 $4.99 Million
Q2 2023

Oct 24, 2023

SELL
$271.49 - $305.09 $278,277 - $312,717
-1,025 Reduced 5.31%
18,280 $5.58 Million
Q2 2023

Jul 13, 2023

SELL
$271.49 - $305.09 $278,277 - $312,717
-1,025 Reduced 5.31%
18,280 $5.58 Million
Q1 2023

Oct 24, 2023

BUY
$246.13 - $285.47 $252,283 - $292,606
1,025 Added 5.61%
19,305 $5.51 Million
Q1 2023

Apr 04, 2023

SELL
$246.13 - $285.47 $78,515 - $91,064
-319 Reduced 1.63%
19,305 $5.51 Million
Q4 2022

Oct 24, 2023

BUY
$205.51 - $253.93 $279,288 - $345,090
1,359 Added 7.44%
19,624 $4.8 Million
Q4 2022

Jan 05, 2023

SELL
$205.51 - $253.93 $61,447 - $75,925
-299 Reduced 1.5%
19,624 $4.8 Million
Q3 2022

Oct 03, 2022

SELL
$189.27 - $231.83 $18,927 - $23,183
-100 Reduced 0.5%
19,923 $4.04 Million
Q2 2022

Jul 06, 2022

SELL
$194.09 - $276.37 $36,488 - $51,957
-188 Reduced 0.93%
20,023 $3.98 Million
Q1 2022

Apr 08, 2022

SELL
$245.33 - $277.77 $36,308 - $41,109
-148 Reduced 0.73%
20,211 $5.4 Million
Q4 2021

Jan 11, 2022

SELL
$236.63 - $276.44 $3,549 - $4,146
-15 Reduced 0.07%
20,359 $5.44 Million
Q3 2021

Oct 12, 2021

BUY
$248.9 - $280.09 $41,317 - $46,494
166 Added 0.82%
20,374 $5.37 Million
Q2 2021

Jul 21, 2021

SELL
$242.95 - $267.0 $152,329 - $167,409
-627 Reduced 3.01%
20,208 $5.25 Million
Q1 2021

Apr 09, 2021

SELL
$221.01 - $248.82 $88,404 - $99,528
-400 Reduced 1.88%
20,835 $5.08 Million
Q4 2020

Jan 20, 2021

SELL
$202.01 - $245.04 $112,115 - $135,997
-555 Reduced 2.55%
21,235 $5.2 Million
Q3 2020

Oct 21, 2020

SELL
$177.77 - $215.81 $204,435 - $248,181
-1,150 Reduced 5.01%
21,790 $4.54 Million
Q2 2020

Jul 20, 2020

SELL
$144.67 - $207.03 $379,035 - $542,418
-2,620 Reduced 10.25%
22,940 $4.13 Million
Q1 2020

Apr 28, 2020

BUY
$126.5 - $225.1 $11,385 - $20,259
90 Added 0.35%
25,560 $4.26 Million
Q4 2019

Jan 10, 2020

SELL
$197.98 - $220.53 $45,733 - $50,942
-231 Reduced 0.9%
25,470 $5.35 Million
Q3 2019

Oct 03, 2019

SELL
$205.4 - $221.82 $37,793 - $40,814
-184 Reduced 0.71%
25,701 $5.56 Million
Q2 2019

Jul 19, 2019

SELL
$180.24 - $205.58 $54,072 - $61,674
-300 Reduced 1.15%
25,885 $5.32 Million
Q1 2019

Apr 25, 2019

BUY
$152.46 - $198.0 $21,344 - $27,720
140 Added 0.54%
26,185 $5.17 Million
Q4 2018

Jan 10, 2019

SELL
$145.0 - $178.65 $15,225 - $18,758
-105 Reduced 0.4%
26,045 $4.08 Million
Q3 2018

Oct 05, 2018

SELL
$163.25 - $177.68 $57,137 - $62,188
-350 Reduced 1.32%
26,150 $4.65 Million
Q2 2018

Jul 09, 2018

BUY
$155.17 - $179.78 $197,841 - $229,219
1,275 Added 5.05%
26,500 $4.48 Million
Q1 2018

Apr 06, 2018

SELL
$148.01 - $168.91 $307,120 - $350,488
-2,075 Reduced 7.6%
25,225 $4.06 Million
Q4 2017

Jan 04, 2018

SELL
$143.51 - $159.74 $5,309 - $5,910
-37 Reduced 0.14%
27,300 $4.23 Million
Q3 2017

Oct 18, 2017

BUY
$138.36 - $147.87 $3.78 Million - $4.04 Million
27,337
27,337 $3.88 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $138B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Lynch & Associates Portfolio

Follow Lynch & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynch & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Lynch & Associates with notifications on news.